Want to see GB:CRDA full AI Analyst Report?
CRDA Stock Chart & Stats
2932.00 p
-7.00 p(-0.24%)
At close: 4:00 PM EDT
2932.00 p
-7.00 p(-0.24%)
Day’s Range― - ―
52-Week Range2,437.00 p - 3,520.24 p
Previous CloseN/A
Volume354.91K
Average Volume (3M)650.08K
Market Cap
£4.83B
Enterprise Value4.82K
Total Cash (Recent Filing)£205.30M
Total Debt (Recent Filing)£783.20M
Price to Earnings (P/E)61.3
Beta1.34
Next Earnings
Feb 23, 2027EPS Estimate
0.88Next Dividend Ex-DateN/A
Dividend Yield3.2%
Share Statistics
EPS (TTM)0.57
Shares Outstanding139,635,440
10 Day Avg. Volume610,745
30 Day Avg. Volume650,080
Financial Highlights & Ratios
PEG Ratio-1.00
Price to Book (P/B)1.72
Price to Sales (P/S)2.21
P/FCF Ratio21.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£3,585.71Price Target Upside22.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)1.58
Revenue Forecast (FY)£1.77B
Bulls Say, Bears Say
Bulls Say
Innovation-led Specialty IngredientsGrowth in protected products and high-value actives shows that Croda’s formulation expertise and innovation pipeline support customer adoption, differentiated pricing and recurring demand in attractive consumer-care niches.
Margin Improvement From TransformationDelivered cost savings are already expanding margins, while the wider transformation programme targets £100m of benefits. This provides a multi-period efficiency opportunity that can support profitability even if volume growth remains moderate.
Manageable Leverage And Positive Cash GenerationPositive recurring cash generation and moderate leverage give Croda financial flexibility to fund research, capacity and dividends while absorbing cyclical demand changes without relying heavily on new borrowing.
Bears Say
Earnings Recovery Remains IncompleteThe post-2022 profitability step-down indicates that Croda has not yet demonstrated durable earnings recovery. Volatile revenue and lower returns could constrain reinvestment capacity and make future growth more dependent on execution.
Working Capital Weakens Cash ConversionThe sizeable cash tied up in working capital reduces conversion of operating profit into free cash flow. Benefits are expected gradually, so inventory and receivables discipline remain important constraints on near-term financial flexibility.
Uneven Demand Across Segments And RegionsUneven performance across pharmaceuticals, agriculture, fragrances and North America exposes Croda to project timing, farm economics and regional disruption. This mix limits the predictability of group growth despite stronger Consumer Care results.
Croda International News
CRDA FAQ
What was Croda International PLC’s price range in the past 12 months?
Croda International PLC lowest share price was 2437.00 p and its highest was 3520.24 p in the past 12 months.
What is Croda International PLC’s market cap?
Croda International PLC’s market cap is £4.83B.
When is Croda International PLC’s upcoming earnings report date?
Croda International PLC’s upcoming earnings report date is Feb 23, 2027 which is in 180 days.
How were Croda International PLC’s earnings last quarter?
Croda International PLC released its earnings results on Jul 28, 2026. The company reported 0.784 p earnings per share for the quarter, beating the consensus estimate of 0.779 p by 0.005 p.
Is Croda International PLC overvalued?
According to Wall Street analysts Croda International PLC’s price is currently Undervalued.
Does Croda International PLC pay dividends?
Croda International PLC pays a Semiannually dividend of 48 p which represents an annual dividend yield of 3.2%. See more information on Croda International PLC dividends here
What is Croda International PLC’s EPS estimate?
Croda International PLC’s EPS estimate is 0.88.
How many shares outstanding does Croda International PLC have?
Croda International PLC has 139,635,440 shares outstanding.
What happened to Croda International PLC’s price movement after its last earnings report?
Croda International PLC reported an EPS of 0.784 p in its last earnings report, beating expectations of 0.779 p. Following the earnings report the stock price went up 8.034%.
Which hedge fund is a major shareholder of Croda International PLC?
Currently, no hedge funds are holding shares in GB:CRDA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Croda International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
£3,585.71 (22.30% Upside)
£3,585.71 (22.30% Upside)
Blogger Sentiment
Bullish
GB:CRDA Sentiment 100%
Sector Average 62%
Sector Average 62%
Insider Transactions
Sold Shares
Worth £120.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.88%
12-Months-Change
Fundamentals
Return on Equity
3.20%
Trailing 12-Months
Asset Growth
1.86%
Trailing 12-Months
Company Description
Croda International PLC
Croda International Plc, established in 1925 and headquartered in Goole, United Kingdom, is a global leader in the development, manufacture, and supply of high-performance specialty chemicals. The company serves a diverse international client base across Europe, the Middle East, Africa, North America, Asia, and Latin America. Its operations are organized into four primary business segments: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. Croda's extensive product portfolio addresses a wide array of industrial and consumer needs. For the Consumer Care market, it delivers crucial ingredients for personal care products, spanning skin, hair, sun, and baby care, along with solutions for color cosmetics, oral hygiene, self-tanning, deodorants, men's grooming, and depilatories, as well as household and institutional cleaning formulations. In Life Sciences, the company provides innovative solutions for agriculture, including crop protection additives, seed enhancements, animal health chemicals, and bio-stimulants, alongside dietary supplements and active pharmaceutical ingredients. The Performance Technologies and Industrial Chemicals segments encompass a vast range of specialized materials. This includes additives for lubricants, coatings, polymers, batteries, and catalysts; materials for electronics, construction, and thermal management; adhesives; and chemicals for vehicle cleaning, automotive textiles, and plastic/rubber products. Furthermore, Croda supplies chemicals for packaging, printing, paper, paints, and water treatment, along with oleochemicals, emulsifiers, fuel additives, and specialty polymer additives for furniture and wood. The company also innovates in bio-based phase change materials, offering solutions for temperature control in buildings, clothing, healthcare, electronics, food refrigeration, energy storage, packaging, and automotive applications. This broad offering underscores Croda's commitment to delivering specialized chemical solutions across numerous critical industries.
CRDA Stock 12 Month Forecast
Average Price Target
3,585.71 p
▲(22.30% Upside)






